Not Rated
|
Fund Size
(0.01% of Investment in Category)
|
Expense Ratio
(0.52% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 04-Nov-25 | 10092.30 | 0.92% | - | 0.93% | 322/726 |
| 1 Month | 10-Oct-25 | 10120.10 | 1.20% | - | 1.72% | 437/721 |
| 3 Month | 11-Aug-25 | 10639.80 | 6.40% | - | 6.31% | 287/702 |
| 6 Month | 09-May-25 | 11102.10 | 11.02% | - | 8.29% | 129/662 |
| YTD | 31-Dec-24 | 10328.00 | 3.28% | - | 10.01% | 471/605 |
| 1 Year | 11-Nov-24 | 10488.60 | 4.89% | 4.89% | 10.64% | 421/579 |
| 2 Year | 10-Nov-23 | 14445.10 | 44.45% | 20.13% | 17.23% | 131/452 |
| 3 Year | 11-Nov-22 | 16629.10 | 66.29% | 18.46% | 16.65% | 103/345 |
| 5 Year | 11-Nov-20 | 19912.60 | 99.13% | 14.76% | 18.48% | 153/174 |
| Since Inception | 26-Oct-20 | 20486.90 | 104.87% | 15.27% | 12.18% | 202/771 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 11-Nov-24 | 12000 | 12782.53 | 6.52 % | 12.24 % |
| 2 Year | 10-Nov-23 | 24000 | 27093.4 | 12.89 % | 12.09 % |
| 3 Year | 11-Nov-22 | 36000 | 46397.37 | 28.88 % | 17.15 % |
| 5 Year | 11-Nov-20 | 60000 | 87750.38 | 46.25 % | 15.18 % |
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 187.4 | 11.16% | 0.00% | 13.34% (Oct 2024) | 10.84% (Aug 2025) | 1.11 L | -0.31 k |
| # Max Healthcare Institute Ltd. | Hospital | 103.1 | 6.14% | 0.00% | 7.08% (Jun 2025) | 5.85% (Nov 2024) | 89.81 k | -0.25 k |
| # Cipla Ltd. | Pharmaceuticals | 98 | 5.84% | 0.00% | 6.36% (Aug 2025) | 5.7% (Dec 2024) | 65.30 k | -0.18 k |
| # ELI LILLY ORD SHS | Foreign equity | 96.5 | 5.75% | 0.00% | 6.34% (Feb 2025) | 4.86% (May 2025) | 1.26 k | 0.00 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 93 | 5.54% | 0.00% | 6.03% (May 2025) | 4.84% (Sep 2025) | 13.80 k | -38.00 |
| # Apollo Hospitals Enterprises Ltd. | Hospital | 89.3 | 5.32% | 0.00% | 5.43% (Aug 2025) | 4.75% (Feb 2025) | 11.62 k | -32.00 |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 80.8 | 4.81% | 0.00% | 5.76% (Dec 2024) | 5.08% (Feb 2025) | 67.46 k | -0.19 k |
| # Johnson & Johnson | Foreign equity | 63 | 3.75% | 0.00% | 3.8% (Sep 2025) | 2.84% (Dec 2024) | 3.76 k | 0.00 |
| # Fortis Healthcare Ltd. | Hospital | 58 | 3.45% | 0.00% | 3.39% (Sep 2025) | 2.3% (Oct 2024) | 56.67 k | -0.16 k |
| # AbbVie Inc | Foreign equity | 53.4 | 3.18% | 0.00% | 3.49% (Sep 2025) | 2.49% (Nov 2024) | 2.76 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.15% |
| Net Receivables | Net Receivables | 0.00% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Tata Silver Exchange Traded Fund | NA | 1189.44 | 5.85 | 38.14 | 65.23 | 74.96 | 0.00 |
| ICICI Prudential Silver ETF | NA | 9445.03 | -3.68 | 37.24 | 61.73 | 74.74 | 34.18 |
| Aditya Birla Sun Life Silver ETF | NA | 1756.21 | -3.69 | 37.15 | 64.69 | 74.70 | 34.22 |
| DSP Silver ETF | NA | 1374.63 | -3.59 | 37.26 | 64.75 | 74.66 | 34.45 |
| Mirae Asset Silver ETF | NA | 460.88 | -3.65 | 37.16 | 64.62 | 74.54 | 0.00 |
| Axis Silver ETF | NA | 720.88 | -3.67 | 37.07 | 64.56 | 74.54 | 34.05 |
| Kotak Silver ETF | NA | 2305.14 | -3.70 | 37.13 | 64.56 | 74.46 | 0.00 |
| SBI Silver ETF | NA | 2330.68 | -3.67 | 37.07 | 61.39 | 74.28 | 0.00 |
| HDFC Silver ETF | NA | 3177.76 | -3.64 | 37.17 | 64.60 | 74.26 | 34.03 |
| Nippon India Silver ETF | NA | 17525.28 | -3.70 | 37.08 | 64.45 | 74.15 | 34.30 |
Out of 93 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 4 is/are ranked 4 * , 7 is/are ranked 3 * , 4 is/are ranked 2 * , and 77 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| BHARAT Bond ETF - April 2030 | NA | 25397.21 | 0.76 | 1.68 | 3.84 | 8.75 | 8.45 |
| BHARAT Bond ETF - April 2030 | NA | 25397.21 | 0.78 | 1.86 | 4.00 | 9.11 | 8.61 |
| Edelweiss Arbitrage Fund - Growth | 3 | 16687.08 | 0.54 | 1.27 | 2.78 | 6.32 | 7.11 |
| BHARAT Bond ETF - April 2031 | NA | 13413.36 | 0.69 | 1.50 | 3.53 | 8.46 | 8.47 |
| BHARAT Bond ETF - April 2031 | NA | 13413.36 | 0.65 | 1.59 | 3.89 | 8.87 | 8.63 |
| Edelweiss Balanced Advantage Fund - Growth | 2 | 12899.19 | 1.07 | 4.13 | 7.20 | 5.29 | 12.09 |
| Edelweiss Mid Cap Fund - Regular Plan - Growth | 5 | 12646.93 | 2.08 | 4.95 | 13.07 | 6.49 | 24.68 |
| BHARAT Bond ETF - April 2032 | NA | 10800.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| BHARAT Bond ETF - April 2032 | NA | 10800.56 | 0.60 | 1.68 | 3.62 | 8.68 | 8.80 |
| Edelweiss Liquid Fund - Regular Plan - Growth | 4 | 10620.71 | 0.48 | 1.45 | 3.03 | 6.68 | 6.93 |